SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Inovio Pharma Shareholders Back Board

Inovio Pharmaceuticals shareholders support the current board as FDA review of INO-3107 advances. This development may impact the company's stock performance.

INO

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.